Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 7:2018:3202719.
doi: 10.1155/2018/3202719. eCollection 2018.

Characterization of α-Glucosidase Inhibitor/Cyclodextrin Complex Prepared by Freeze-Drying

Affiliations

Characterization of α-Glucosidase Inhibitor/Cyclodextrin Complex Prepared by Freeze-Drying

Yutaka Inoue et al. J Pharm (Cairo). .

Abstract

Miglitol (MT) is an α-glucosidase inhibitor with a postmeal blood glucose level lowering effect that is used to treat type 2 diabetes. In addition, α-cyclodextrin (αCD) has been reported to inhibit increases in postmeal blood glucose. The aim of this study was to prepare a freeze-dried product (FD) composed of MT and αCD or γCD (molar ratio of MT/αCD = 1/1, MT/γCD = 1/1) and to evaluate the physicochemical properties and biological activity of the FD. The PXRD profile of FD exhibited a halo pattern, and characteristic peaks derived from MT, αCD, and γCD were not observed. The TG-DTA results for FD indicated an increased weight loss temperature and the absence of an endothermic peak for MT. The NIR absorption spectrum measurement suggested an intermolecular interaction between MT and αCD or γCD in the FD. 1H-1H NOESY NMR spectroscopy (D2O) revealed an intermolecular interaction in the FD. The results of the α-glucosidase activity inhibition test and the α-amylase activity inhibition test indicated that the FD exhibited the same inhibition rate as MT alone and the effects of MT were not altered by the freeze-drying method.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of (a) miglitol, (b) acarbose, (c) αCD, (d) γCD.
Figure 2
Figure 2
PXRD patterns of MT/αCD and MT/γCD systems. (a) MT intact, (b) αCD, (c) γCD, (d) PM (MT/αCD = 1/1), (e) PM (MT/γCD = 1/1), (f) FD (MT/αCD = 1/1), (g) FD (MT/γ CD = 1/1). ■: MT original, ○: αCD original, ▲: γ CD original.
Figure 3
Figure 3
TG curves of MT/αCD and MT/γCD systems. (a) MT, (b) αCD, (c) γCD, (d) PM (MT/αCD = 1/1), (e) PM (MT/γCD = 1/1), (f) FD (MT/αCD = 1/1), (g) FD (MT/γCD = 1/1).
Figure 4
Figure 4
DTA curves of MT/αCD and MT/γCD systems. (a) MT, (b) αCD, (c) γCD, (d) PM (MT/αCD = 1/1), (e) PM (MT/γCD = 1/1), (f) FD (MT/αCD = 1/1), (g) FD (MT/γCD = 1/1).
Figure 5
Figure 5
NIR absorption spectra of MT/αCD systems and second-differentiation NIR absorption spectra of MT/αCD systems ((b) alkyl group, (c) alkyl group, and (d) hydroxy group).
Figure 6
Figure 6
NIR absorption spectra of MT/γCD systems and second-differentiation NIR absorption spectra of MT/γCD systems ((b) alkyl group of MT, (c) hydroxy group of γCD, (d) alkyl group of MT, and (e) hydroxy group of MT).
Figure 7
Figure 7
Proton-NOESY NMR spectra of MT in D2O.
Figure 8
Figure 8
1H-1H -NOESY NMR spectra of MT/αCD system.
Figure 9
Figure 9
1H-1H -NOESY NMR spectra of MT/γCD system.

References

    1. Ford E. S., Bergmann M. M., Boeing H., Li C., Capewell S. Healthy lifestyle behaviors and all-cause mortality among adults in the United States. 2012;55(1):23–27. doi: 10.1016/j.ypmed.2012.04.016. - DOI - PMC - PubMed
    1. Koukiekolo R., Desseaux V., Moreau Y., Marchis-Mouren G., Santimone M. Mechanism of porcine pancreatic α-amylase: inhibition of amylose and maltopentaose hydrolysis by α-, β- and γ-cyclodextrins. 2001;268(3):841–848. doi: 10.1046/j.1432-1327.2001.01950.x. - DOI - PubMed
    1. Sugahara M., Inoue Y., Murata I., et al. Effect of cyclodextrin on postprandial blood glucose and triglycerides. 2016;6(3):13–19.
    1. Alomrani A. H., Shazly G. A., Amara A. A. A. F., Badran M. M. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. 2014;121:74–81. doi: 10.1016/j.colsurfb.2014.05.030. - DOI - PubMed
    1. Inoue Y., Sekiya N., Katayama K., et al. Stabilizing effect of β-cyclodextrin on Limaprost, a PGE1 derivative, in Limaprost alfadex tablets (Opalmon®) in highly humid conditions. 2014;62(8):786–792. doi: 10.1248/cpb.c14-00150. - DOI - PubMed

LinkOut - more resources